Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Am J Clin Oncol. 2014 Dec;37(6):528–534. doi: 10.1097/COC.0b013e31827defa1

Table 3.

Univariate analysis for Overall Survival (OS) in all patients

Variable Pts n° 5-year 0S 95% CI p
Age < 26 yrs 4 25 0–67 0.6
26 – 65 yrs 42 23 10–36
> 65 yrs 14 11 0–32
Gender M 38 25 11–39 0.4
F 22 13 0–28
Stage localized 36 33 17–50 0.0001
metastatic 24 0
Size* < 10 cm 22 33 13–54 0.09
≥ 10 cm 29 11 0–23
Site extremity 38 29 14–44 0.1
central 22 6 0–17
Chemotherapy** yes 28 22 6–38 0.11
no 29 22 7–39
SCR yes 30 46 29–63 0.0001
no 30 0

M: male; F: Female; SCR: surgical complete remission

*

Size was known in 51 patients;

**

Chemotherapy information was available for 57 patients